Lite Strategy, Inc. (NASDAQ:LITS) — Market Cap & Net Worth
Market Cap & Net Worth: Lite Strategy, Inc. (LITS)
Lite Strategy, Inc. (NASDAQ:LITS) has a market capitalization of $33.83 Million ($33.83 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23411 globally and #5033 in its home market, demonstrating a 21.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lite Strategy, Inc.'s stock price $0.92 by its total outstanding shares 36769677 (36.77 Million). Review LITS total debt and obligations to assess the company's total debt and financial obligations.
Lite Strategy, Inc. Market Cap History: 2025 to 2026
Lite Strategy, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $48.54 Million to $33.83 Million (0.00% CAGR).
Lite Strategy, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lite Strategy, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LITS by Market Capitalization
Companies near Lite Strategy, Inc. in the global market cap rankings as of June 18, 2026.
Key companies related to Lite Strategy, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #442 globally with a market cap of $63.33 Billion USD.
- UCB SA (BR:UCB): Ranked #550 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $453.17 |
| #442 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.33 Billion | $614.73 |
| #550 | UCB SA | BR:UCB | $49.68 Billion | €250.00 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €755.80 |
Lite Strategy, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Lite Strategy, Inc.'s market cap moved from $48.54 Million to $ 33.83 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $33.83 Million | -30.30% |
| 2025 | $48.54 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Lite Strategy, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.83 Million USD |
| MoneyControl | $33.83 Million USD |
| MarketWatch | $33.83 Million USD |
| marketcap.company | $33.83 Million USD |
| Reuters | $33.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.